Wei Wang, Wei Wang, Siming Peng, Sihao Gao, Meiying Quan, Lijuan Gou, . . . Hongmei Song. (2023). Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib. BMC.
Chicago Style (17th ed.) CitationWei Wang, et al. Tocilizumab Reduces the Unmanageable Inflammatory Reaction of a Patient with Aicardi-Goutières Syndrome Type 7 During Treatment with Ruxolitinib. BMC, 2023.
MLA (9th ed.) CitationWei Wang, et al. Tocilizumab Reduces the Unmanageable Inflammatory Reaction of a Patient with Aicardi-Goutières Syndrome Type 7 During Treatment with Ruxolitinib. BMC, 2023.
Warning: These citations may not always be 100% accurate.